• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Biased hormonal therapy duration analysis makes results uninterpretable.

作者信息

Tangen Catherine M, Goldman Bryan H, Swanson Gregory P, Thompson Ian M

出版信息

J Clin Oncol. 2009 Nov 20;27(33):e203; author reply e204. doi: 10.1200/JCO.2009.23.6000. Epub 2009 Sep 28.

DOI:10.1200/JCO.2009.23.6000
PMID:19786655
Abstract
摘要

相似文献

1
Biased hormonal therapy duration analysis makes results uninterpretable.有偏差的激素治疗持续时间分析会使结果无法解读。
J Clin Oncol. 2009 Nov 20;27(33):e203; author reply e204. doi: 10.1200/JCO.2009.23.6000. Epub 2009 Sep 28.
2
Selection bias is not a good reason for advising more than 5 years of adjuvant hormonal therapy for all patients with locally advanced prostate cancer treated with radiotherapy.对于所有接受放疗的局部晚期前列腺癌患者，选择偏倚并非建议进行超过5年辅助激素治疗的充分理由。
J Clin Oncol. 2009 Nov 20;27(33):e201-2; author reply e204. doi: 10.1200/JCO.2009.23.3601. Epub 2009 Sep 28.
3
Intermittent androgen deprivation therapy: conventional wisdom versus evidence.间歇性雄激素剥夺疗法：传统观念与证据
Eur Urol. 2009 Jun;55(6):1278-80. doi: 10.1016/j.eururo.2009.03.010. Epub 2009 Mar 11.
4
[Advanced prostatic carcinoma--which hormone therapy when?].[晚期前列腺癌——何时进行何种激素治疗？]
Urologe A. 1995 Sep;34(5):361-6.
5
Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.间歇性雄激素剥夺疗法治疗局部晚期和转移性前列腺癌：来自南欧泌尿肿瘤学组的一项随机3期研究结果
Eur Urol. 2009 Jun;55(6):1269-77. doi: 10.1016/j.eururo.2009.02.016. Epub 2009 Feb 21.
6
Effect of neoadjuvant epirubicin and total androgen blockade on complete pathological response in patients with clinical stage T3/T4 prostate cancer.新辅助表柔比星和全雄激素阻断对临床分期为T3/T4期前列腺癌患者完全病理缓解的影响。
Eur J Surg Oncol. 2008 Feb;34(2):216-21. doi: 10.1016/j.ejso.2007.03.016. Epub 2007 May 14.
7
Selection bias clouds apparent benefit of longer hormone duration.
J Clin Oncol. 2010 Feb 10;28(5):e79; author reply e80. doi: 10.1200/JCO.2009.25.0969. Epub 2009 Oct 19.
8
[Clinical protocols in treatment of prostatic carcinoma in Europe. The role of EORTC and other organizations].
Urologe A. 1995 Sep;34(5):374-81.
9
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413.比较全盆腔放疗与仅前列腺放疗以及新辅助与辅助联合雄激素抑制的III期试验：放射肿瘤学组9413
J Clin Oncol. 2003 May 15;21(10):1904-11. doi: 10.1200/JCO.2003.05.004.
10
Re: Fritz H. Schröder, Karl-Heinz Kurth, Sophie D. Fossa, et al. Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial). Eur Urol 2009;55:14-22.
Eur Urol. 2009 May;55(5):e82-3. doi: 10.1016/j.eururo.2008.10.026. Epub 2008 Oct 21.

引用本文的文献

1
Challenges of guarantee-time bias.保证时间偏倚的挑战。
J Clin Oncol. 2013 Aug 10;31(23):2963-9. doi: 10.1200/JCO.2013.49.5283. Epub 2013 Jul 8.